Changeflow GovPing Pharma & Drug Safety BASF Peptide Acetals Enzyme Stabilising Patent ...
Routine Notice Added Final

BASF Peptide Acetals Enzyme Stabilising Patent EP3994148A1

Favicon for changeflow.com EPO Patent Bulletin - Peptides (C07K)
Published
Detected
Email

Summary

BASF peptide acetals enzyme stabilising patent EP3994148A1

What changed

The European Patent Office published patent application EP3994148A1 for BASF SE, covering peptide acetals used to stabilise enzymes. The patent includes 12 IPC classifications spanning peptide chemistry (C07K), enzyme technology (C12N), pharmaceuticals (A61K), and detergent formulations (C11D). The designated states cover all major EU and EEA jurisdictions including Germany, France, UK, Italy, Netherlands, Spain, Poland, and Sweden.

Parties developing enzyme-based products for industrial, pharmaceutical, or consumer applications should assess potential IP conflicts in designated states. The patent's broad scope across multiple enzyme applications may affect formulation strategies in cleaning products, biocatalysis processes, and therapeutic enzyme preparations. Competitors should monitor for corresponding national phase entries and any oppositions at the EPO.

What to do next

  1. Monitor for patent enforcement actions in designated states
  2. Review freedom-to-operate implications if developing enzyme-based products

Archived snapshot

Apr 8, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

PEPTIDE ACETALS FOR STABILISING ENZYMES

Publication EP3994148A1 Kind: A1 Apr 01, 2026

Applicants

BASF SE

Inventors

CUNNINGHAM, Allan F, JENEWEIN, Stefan, BOENEMANN, Gabriele

IPC Classifications

C07K 5/062 20060101AFI20210115BHEP C07K 5/072 20060101ALI20210115BHEP C07K 5/078 20060101ALI20210115BHEP C12N 9/99 20060101ALI20210115BHEP C12N 9/96 20060101ALI20210115BHEP A61K 38/55 20060101ALI20210115BHEP C11D 3/33 20060101ALI20210115BHEP C11D 3/386 20060101ALI20210115BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Peptides (C07K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.

Last updated

Classification

Agency
EPO
Published
April 1st, 2026
Instrument
Notice
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP3994148A1

Who this affects

Applies to
Manufacturers Pharmaceutical companies
Industry sector
3241 Chemical Manufacturing
Activity scope
Patent publication Intellectual property registration
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Chemical Manufacturing

Get alerts for this source

We'll email you when EPO Patent Bulletin - Peptides (C07K) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.